Aeristech develops and manufactures patented electric superchargers, boosting engines while reducing fuel consumption and CO2 emissions.

The company successfully raised £235,000 in August 2014, to produce a proof-of-concept product prototype for its advanced boosting technology, before returning to SyndicateRoom in February 2017 and overfunding to £483,766.

The story

Aeristech was founded in 2006 to develop fully electric turbocharger technology.

Driven by the global need to reduce emissions, and with engine downsizing seen as the most immediate way forward, Aeristech has developed an electric supercharger prototype and fitted it to a demonstration vehicle in partnership with MAHLE Powertrain, part of MAHLE GmbH – one of the largest automotive suppliers worldwide.

By relying on Aeristech’s unique electric supercharger performance, the vehicle achieved significant engine downsizing with a huge increase in specific power (161kW/litre).

mahle.jpg

Aeristech believes its high-performance electric supercharger can enable engine manufacturers to develop well-tuned and driveable engines with higher levels of engine downsizing, and increased CO2 savings relative to other technologies. Aeristech has demonstrated 60% engine downsizing, while, to the best of its team’s knowledge, competing technologies have achieved less than 50%.

Bryn Richards, CTO, is the Founder of Aeristech Limited and inventor of ‘hybrid turbo-charging technology’. Bryn is a leading expert in electrical and mechanical machines and, in particular, the control of ultra-high-speed motors as well as being author of several patents. CEO Richard Wall has worked in high-level roles across a range of engineering-focused companies, including Omitec Group, which sold to Continental in 2015.

The Aeristech team plans to use funds raised in this round to further expand its technology demonstrator portfolio and support Aeristech’s commercial negotiating position with manufacturers.

The lead investor

Lead investor Ernest Kochmann has invested £40,000 into Aeristech. Ernest has been involved in small privately owned businesses and counts his biggest achievement to be building and, last year, selling his own business to a large international industrial company. For the last five years, he has been investing in EIS- and SEIS-funded closed companies. Now semi-retired, he is keen to support innovative companies.

Aeristech has a good understanding of the market and how to get traction in it, and enough investment already committed that, in the event of financial difficulties, existing shareholders would give support to ensure any cash crisis would be avoided.

Ernest Kochmann

Lead investor

What investors say

‘My first investment in Aeristech was over a year ago. I have since made three further investments, including this round.

‘Aeristech is a company which:

  • Has an industry-leading product, protected by patents for the core enabling technology
  • Has been tested by some top industry names, with no negative feedback
  • Has a known (and growing) market need.’

– Derek Pink, SyndicateRoom investor

See current opportunities

Squirrel Financial Wellbeing

EIS
Financial Services
Squirrel aims to make it easy and intuitive to create – and stick to – a budget. Find out about Squirrel's funding round and lead investor Jos Evans here.

Active

Trading status

£6,852

Average investment

£465,929

Total raised

Renovare Fuels

Environment & Renewables
Renovare Fuels successfully completed its funding round on SyndicateRoom in early 2017. Read about the raise here.

Active

Trading status

£18,810

Average investment

£658,337

Total raised

Cipher Surgical

EIS
Medtech
Cipher Surgical offers an innovative method of maintaining vision during a laparoscopic procedure. Read about Cipher Surgical's crowdfunding campaigns here.

Active

Trading status

£7,192

Average investment

£1,014,150

Total raised

Small Pharma Ltd

EIS
Pharmaceuticals & Biotechnology
Small Pharma is developing an oral rapid-acting antidepressant they believe could make a difference in the lives of those experiencing severe depression.

Active

Trading status

£11,699

Average investment

£783,849

Total raised

Camfridge Limited

EIS
Environment & Renewables
The creator of smart refrigeration technology designed to avoid harmful gases and enable lower cost high-efficiency cooling appliances.

Active

Trading status

£7,935

Average investment

£603,023

Total raised

Jupiter Diagnostics

EIS
Pharmaceuticals & Biotechnology
Jupiter Diagnostics is developing faster, cheaper and easier blood tests. Read about the Jupiter Diagnostics equity crowdfunding campaign here.

Active

Trading status

£19,553

Average investment

£1,427,378

Total raised